评估墨西哥癌症资源分配中的差异
Elysse Bautista-Gonzalez1,2, Andrés Quintero Leyra3, Teresa Verenice Munoz Rocha4
1Fundación Mexicana para la salud, Anillo Perif. 4809, Arenal Tepepan, Tlalpan, Ciudad de México, 14610, México. ebautista@funsalud.org.mx.
BMC health services research
|April 17, 2025
概括
墨西哥 墨西哥 墨西哥 墨西哥
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 越来越多的癌症负担需要对墨西哥医疗保健系统能力进行批判性评估.
- 诊断和治疗基础设施有限,导致癌症治疗的延迟.
- 对癌症基础设施和资源的全面评估对于识别服务差距至关重要.
研究的目的:
- 在墨西哥为五种主要癌症类型绘制癌症基础设施:乳腺,肺,前列腺,结肠和子宫.
- 识别和分类癌症护理资源用于诊断和治疗.
- 在墨西哥各地地理地图上绘制癌症护理基础设施.
主要方法:
- 对公开可用的数据库进行现实的评估 (高专业医疗设备国家库存,卫生信息总局).
- 专家的共识指导了基本诊断和治疗资源的选择.
- 设施根据服务范围 (诊断,诊断和治疗) 和基础设施水平 (核心,增强) 进行分类,然后按地理位置绘制地图.
主要成果:
- 在14133个医疗机构中,只有5%提供癌症护理.
- 核心治疗基础设施的有限可用性 (例如,10个疗单元,11个-60单元,21个线性加速器).
- 在基础设施的可用性,治疗资源的区域集中和数据不准确性方面发现了显著的差异.
结论:
- 解决癌症资源分配中的差异对于确保墨西哥的公平至关重要.
- 加强没有保险的人群的卫生系统是通过改善癌症护理基础设施所提供的机会.
- 需要对诊断和治疗基础设施进行战略性投资,特别是肺癌,前列腺癌和乳腺癌.
相关概念视频
01:21Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
02:18Cancer
47.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.1K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:53Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
01:20Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85